Douglas G. Gray
Corporate Secretary presso BIOHAVEN LTD.
Profilo
Douglas G.
Gray is Secretary at Biohaven Ltd.
Mr. Gray is also Partner & Chairman-Life Science Practice Group at Locke Lord LLP.
Mr. Gray previously held the position of Partner at Edwards Wildman Palmer LLP and Secretary & Director at Biohaven Pharmaceutical Holding Co. Ltd.
Mr. Gray received an undergraduate degree from Yale University and a graduate degree from the University of Notre Dame.
Posizioni attive di Douglas G. Gray
Società | Posizione | Inizio |
---|---|---|
BIOHAVEN LTD. | Corporate Secretary | - |
Locke Lord LLP
Locke Lord LLP Miscellaneous Commercial ServicesCommercial Services Locke Lord LLP provides legal services. The private company is based in Houston, TX. | Corporate Officer/Principal | 01/01/2015 |
Precedenti posizioni note di Douglas G. Gray
Società | Posizione | Fine |
---|---|---|
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Director/Board Member | 03/10/2022 |
Edwards Wildman Palmer LLP
Edwards Wildman Palmer LLP Miscellaneous Commercial ServicesCommercial Services Edwards Wildman Palmer LLP is a private banking firm located in Boston, Massachusetts. | Corporate Officer/Principal | - |
Formazione di Douglas G. Gray
University of Notre Dame | Graduate Degree |
Yale University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
BIOHAVEN LTD. | Health Technology |
Aziende private | 3 |
---|---|
Edwards Wildman Palmer LLP
Edwards Wildman Palmer LLP Miscellaneous Commercial ServicesCommercial Services Edwards Wildman Palmer LLP is a private banking firm located in Boston, Massachusetts. | Commercial Services |
Biohaven Pharmaceutical Holding Co. Ltd.
Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
Locke Lord LLP
Locke Lord LLP Miscellaneous Commercial ServicesCommercial Services Locke Lord LLP provides legal services. The private company is based in Houston, TX. | Commercial Services |